Björn Hammarskjöld

Björn Hammarskjöld

Auto-generated profile, based on publicly available information

Björn Hammarskjöld

Strömstad Academy, Strömstad, Sweden

Research Focus & Metrics

Academic Career Length

56Years (1971-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2016 in BMJ Open
Verified
Journal Article
Open access
PDF file
URUffe Ravnskov
Uffe Ravnskov
David DiamondDavid Diamond
David Diamond
RHRokura Hama
Rokura Hama
THTomohito Hamazaki
Tomohito Hamazaki
BHBjörn Hammarskjöld
Björn Hammarskjöld
RSRalf Sundberg
Ralf Sundberg
Objective It is well known that total cholesterol becomes less of a risk factor or not at all for all-cause and cardiovascular (CV) mortality with increasing age, but as little is known as to whether low-density lipoprotein cholesterol (LDL-C), one component of total cholesterol, is associated with mortality in the elderly, we decided to investigate this issue. Setting, participants and outcome measures We sought PubMed for cohort studies, where LDL-C had been investigated as a risk factor for all-cause and/or CV mortality in individuals ≥60 years from the general population. Results We identified 19 cohort studies including 30 cohorts with a total of 68 094 elderly people, where all-cause mortality was recorded in 28 cohorts and CV mortality in 9 cohorts. Inverse association between all-cause mortality and LDL-C was seen in 16 cohorts (in 14 with statistical significance) representing 92% of the number of participants, where this association was recorded. In the rest, no association was found. In two cohorts, CV mortality was highest in the lowest LDL-C quartile and with statistical significance; in seven cohorts, no association was found. Conclusions High LDL-C is inversely associated with mortality in most people over 60 years. This finding is inconsistent with the cholesterol hypothesis (ie, that cholesterol, particularly LDL-C, is inherently atherogenic). Since elderly people with high LDL-C live as long or longer than those with low LDL-C, our analysis provides reason to question the validity of the cholesterol hypothesis. Moreover, our study provides the rationale for a re-evaluation of guidelines recommending pharmacological reduction of LDL-C in the elderly as a component of cardiovascular disease prevention strategies.

3 October 2018 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Open access
URUffe Ravnskov
Uffe Ravnskov
MLMichel de Lorgeril
Michel de Lorgeril
David DiamondDavid Diamond
David Diamond
RHRokuro Hama
Rokuro Hama
THTomohito Hamazaki
Tomohito Hamazaki
RSRalf Sundberg
Ralf Sundberg
Introduction For half a century, a high level of total cholesterol (TC) or low-density-lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for cardiovascular prevention. However, there is an increasing understanding that the mechanisms are more complicated, and that statin treatment, in particular when used as primary prevention, is of doubtful benefit. Areas covered The authors of three large reviews recently published by statin advocates have attempted to validate the current dogma. This paper delineates the serious errors in these three reviews as well as other obvious falsifications of the cholesterol hypothesis. Expert commentary Our search for falsifications of the cholesterol hypothesis confirms that it is unable to satisfy any of the Bradford Hill criteria for causality, and that the conclusions of the authors of the three reviews are based on misleading statistics, exclusion of unsuccessful trials and by ignoring numerous contradictory observations.

1 October 1982 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
GKG. Karlaganis
G. Karlaganis
ANA. Nemeth
A. Nemeth
BHB. Hammarskjöld
B. Hammarskjöld
BSB. Strandvik
B. Strandvik
JSJ. Sjövall
J. Sjövall

1 January 1972
Verified
Journal Article
Closed access
ENE Norrby
E Norrby
BHB Hammarskjöld
B Hammarskjöld

1 March 1971 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
MPM. Parfanovich
M. Parfanovich
BHB. Hammarskjöld
B. Hammarskjöld
ENE. Norrby
E. Norrby

1 November 1974 in Medical Microbiology and Immunology
Verified
Journal Article
Closed access
PDF file
BHBjörn Hammarskjöld
Björn Hammarskjöld
ENErling Norrby
Erling Norrby